Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
3,479,535
-
Share change
-
-19,321
-
Total reported value
-
$27,622,000
-
Price per share
-
$7.98
-
Number of holders
-
7
-
Value change
-
-$152,322
-
Number of sells
-
3
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q3 2018
As of 30 Sep 2018,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,479,535 shares.
The largest 7 holders included
Temasek Holdings (Private) Ltd, Prince Street Capital Management LLC, HSBC HOLDINGS PLC, BAILLIE GIFFORD & CO, PLATINUM INVESTMENT MANAGEMENT LTD, MILLENNIUM MANAGEMENT LLC, and MYDA Advisors LLC.
This page lists
7
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.